References
- Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:461-5. https://doi.org/10.7326/0003-4819-117-6-461
- Diener HC, Weimar C, Katsarava Z. Patent foramen ovale: paradoxical connection to migrane and stroke. Curr Opin Neurol 2005;18: 299-304. https://doi.org/10.1097/01.wco.0000169749.52406.74
- Oh BH, Park SW, Choi YJ, et al. Prevalence of the patent foramen ovale in young patients with ischemic cerebrovascular disease: transesophageal contrast echocardiographic study. Korean Circ J 1993; 23:217-22.
- Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999;74:862-9. https://doi.org/10.4065/74.9.862
- Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-31. https://doi.org/10.1161/01.CIR.0000017498.88393.44
- Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-5. https://doi.org/10.1212/WNL.46.5.1301
- Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130: 1083-8. https://doi.org/10.1016/0002-8703(95)90212-0
- Agmon Y, Khandheira BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942-4. https://doi.org/10.1161/01.CIR.99.15.1942
- Chun KJ. Patent foramen ovale and cryptogenic stroke. Korean Circ J 2008;38:631-7. https://doi.org/10.4070/kcj.2008.38.12.631
- De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-13. https://doi.org/10.1161/01.STR.31.10.2407
- Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-23. https://doi.org/10.1016/S0735-1097(01)01427-9
- Gaspardone A, Iani C, Papa M. Percutaneous closure of patent foramen ovale: awise approach. G Ital Cardiol 2008;9:593-602.
- Mattioli A, Bonetti L, Aquilina M, Oldani A, Longhini C, Mattioli G. Association between atrial septal aneurysm and patent foramen ovale in young patients with recent stroke and normal carotid arteries. Cerebrovasc Dis 2003;15:4-10. https://doi.org/10.1159/000067114
- Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002;33:706-11. https://doi.org/10.1161/hs0302.104543
- Overell JR, Bone I, Less KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55: 1172-9. https://doi.org/10.1212/WNL.55.8.1172
- Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003;16:43-50. https://doi.org/10.1046/j.1540-8183.2003.08002.x
- Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: longterm risk of recurrent thromboembolic events. Circulation 2000;101: 893-8. https://doi.org/10.1161/01.CIR.101.8.893
- Du ZD, Cao QL, Joseph A, et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediateterm risk of recurrent neurological events. Catheter Cardiovasc Interv 2002;55:189-94. https://doi.org/10.1002/ccd.10067
- Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single center experience. Circulation 2002;105:2845-8. https://doi.org/10.1161/01.CIR.0000019069.32964.0E
- Meier B. Closure of patent foramen ovale: technique, pitfalls, complications, and follow up. Heart 2005;91;444-8. https://doi.org/10.1136/hrt.2004.052258
- Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment. J Interv Cardiol 2003;16:39-42. https://doi.org/10.1046/j.1540-8183.2003.08001.x
- Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51. https://doi.org/10.1016/S0140-6736(00)03160-3
- Stewart WF, Shetcher A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994;44(6 Suppl 4):S17-23.
- Migraine-Nimodipine European Study Group M. European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache 1989;29:633-8. https://doi.org/10.1111/j.1526-4610.1989.hed2910633.x
- Migraine-Nimodipine European Study Group M. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache 1989;29:639-42. https://doi.org/10.1111/j.1526-4610.1989.hed2910639.x
Cited by
- Migraine with aura: A predictor of patent foramen ovale in children and adolescents vol.33, pp.7, 2011, https://doi.org/10.1177/0333102413477740